Drug Science publishes peer reviewed research, reports, and articles to provide clear, evidence-based information without political or commercial interference.

Update What you have helped us achieve so far Our medical cannabis registry, Project Twenty21, was originally designed to run until the end of 2021 (hence the name). As you will know from your own life during the pandemic, the last two years have been full of challenges and obstacles. Project…

Get Project Twenty21 Updates via Email To mark the end of the year that is our namesake, we're proud to announce that we've reached 2000 patients contributing their data to Project Twenty21. In a recent article for Cannabis Health, our Head of Development, David Horn, reflects on the last two years and…

The British Paediatric Neurology Association (BPNA) recently produced new guidance on the prescription of cannabis medicines for children with epilepsy. However, the Medical Cannabis Clinicians Society (UKMCCS) and Drug Science fundamentally disagree with this guidance. Expert clinicians from both organisations have produced a critique to provide commentary, evidence and further crucial information…

Authors Ben Houghton, Alexis Bailey, Christos Kouimtsidis, Theodora Duka, Caitlin Notley Published November 25, 2021 Background Opioid-related deaths are at record levels in the UK and contribute to over half of all drug-related deaths. The prevalence of psychiatric disorders within people who uses substances is known to be considerably higher than…